Crowdfunding

Pluton Biosciences, Incorporated

Deadline passed 2019-05-06

Corporation · Missouri · Incorporated 2017-01-16

  • CIK 1759355
  • File 020-25058
  • State MO
Target Amount
$75,000
minimum to close
Maximum Amount
$150,000
ceiling, with over-subscription
Deadline
2019-05-06
as the latest Form C set it

Connected

named in its Form C filings

The intermediary named in this company’s Form C filings. Investments in a Regulation Crowdfunding offering can only be made through them.

Latest Reported Offering

The terms on the latest Form C

Security Details

Type
Debt
Price per share
$0.00
Price set by
The value of the instrument will equal principal dollars on issued debt
Shares offered
0+

Offering Costs

Cash commission
5%
and $0.00
Equity compensation
—
None

Campaign timeline

target amount · by first filed
2019-01-04 · $75,000
  1. 2019-01-04$75,000020-25058

Hover a dot or row, or tab through the dots · bars scaled to the largest round ($75,000)

Reg D offerings

3 offerings

Private placements reported on Form D, separate from the crowdfunding raise: Reg CF sales are never counted in their sold amounts

Form D offerings
FileFirst filedLatestSoughtSoldInvestorsExemption
021-483201First filed2023-06-02Latest2023-06-02Sought$17.6MSold$17.6MInvestors12Exemption506(b)
021-415472First filed2021-10-01Latest2021-10-01Sought$6.7MSold$6.7MInvestors38Exemption506(b)
021-329425First filed2019-01-02Latest2019-01-02Sought$1MSold$0Investors0Exemption506(c)
Its Form D page

Filing history

Form C family — 5 filings
FiledFormFile numberPortalWhat it statesWhat the filer said
C-AR020-25058NvstedRevenue $477K · net income -$980K · 15 employees—
C-U020-25058Nvsted$75K target, up to $150K · Debt · closes 2019-05-06Pluton Biosciences raised approximately $98,000 during the offering period. Payments are still being processed; the exact amount has yet to be determined.
C/A020-25058Nvsted$75K target, up to $150K · Debt · closes 2019-06-07This second Amendment is being filed in order to extend the Offering Deadline to June 7, 2019.
C/A020-25058Nvsted$75K target, up to $150K · Debt · closes 2019-05-06This Amendment is being filed in order to correct the name of the Issuer to "Pluton Biosciences, LLC" instead of "Charlie Walch", the name of the Chief Executive Officer.
C020-25058Nvsted$75K target, up to $150K · Debt · closes 2019-05-06—

Company Information

Legal Status
Corporation
Jurisdiction
Missouri
Date of Incorporation
2017-01-16

Latest Metrics

Most recent fiscal year, as the latest filing reports it

Employees
15
Total Assets
$709,402
Cash on Hand
$191,989
Revenues
$476,675
Net Income
-$979,712

Form C prints a most-recent and a prior fiscal year side by side but never names them. The dashboard chains every filing into those years and plots them. EDGAR still has each Form C-AR; the dashboard lays every year they filed next to it.

  • Reported financials chained into fiscal years — revenue, income, assets, cash — not one filing at a time
  • A sparkline on each figure so the shape is visible before the numbers
  • A revenue series dated to the filings that reported it
  • The campaign as filed: target, ceiling, deadline, and the portal that ran it
  • Follow it, and see it change on your watchlist

Part of the Crowdfunding plan — $40/mo at launch pricing ($100 list)

See plans

View all SEC filings ↗